Temporary ADHD Medication Shortage

UPDATE: 1/23/2024 – 2:30 PM

Dear GatorCare members,

At GatorCare, we strive to keep you informed about matters that may impact your healthcare experience. We want to bring to your attention a current challenge within the pharmaceutical industry that may affect the availability of certain medications used in the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). While we do not supply these medications directly, we want to ensure you are aware of the situation and provide support during this period.

Several ADHD medications, all sharing a common active ingredient, are currently facing a temporary shortage in the market. Manufacturers are actively working to address these issues, but it may result in temporary difficulty in finding the specific ADHD medication you need. We expect to see medications back in stock by the end of this month or early next month.

We understand the importance of these medications for individuals managing ADHD, and we want to assure you that your health and well-being are our top priorities. To stay updated on the status of the supply chain, we recommend checking the U.S. Food and Drug Administration (FDA) Drug Shortage Trackers linked here regularly. (If your medication is not listed below, use the ALL OTHER DRUG SHORTAGES button and search the name of its active ingredient for more info)

While this shortage is beyond our control, we are committed to supporting you during this challenging time. If you encounter difficulties finding your prescribed medication or have concerns about alternatives, please reach out to your healthcare provider. Additionally, Prime Therapeutics’s (formerly Magellan Rx) customer support team is available at the number below to assist you with any questions you may have.

GatorCare dedicated Prime Therapeutics (formerly Magellan Rx) customer support: 800-651-8921

We appreciate your understanding and cooperation as we navigate through this temporary shortage together.